AzTrials
AzTrials

Emergency Geriatric CareREGESANCT02712450

Tools Development for Geriatric Emergency Regulation

An observational study of Emergency Geriatric Care, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

According to surveys, 13% to 20% of the Service Médical d'Urgence (SAMU) centre 15 (French 911) calls concern elderly patients above 75 years of age. For these patients, the clinical pathway should be decided on the basis of the symptomatology described during the call, but also with the gathering of specific data… Read more about this study

Who is it for?
Ages 75 years and older
Conditions the study is for
Emergency Geriatric Care
How many people
2,279 participants
Where
1 siteFrance
Study dates
Jan 2016to Aug 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Elderly patients calling SAMU

Who may be able to join

  • Patient above 75 years olds
  • Patient calling for a liberal regulation
  • Patient calling between 8 a.m. and 6 p.m. from monday to friday

Who cannot join

  • Patient calling for vital emergency (hospital regulation)
  • Patient calling for inter-hospital transport

Trial locations and contacts

1 site in 1 country.

France1 site
  • Service Gériatrie - Hôpital Edouard Herriot, Hospices Civils de Lyon

    Lyon, 69003

Other trials in France

About this study

Official title: Tools Development for Geriatric Emergency Regulation at the Emergency Service Centre, in the Rhône Area

According to surveys, 13% to 20% of the Service Médical d'Urgence (SAMU) centre 15 (French 911) calls concern elderly patients above 75 years of age. For these patients, the clinical pathway should be decided on the basis of the symptomatology described during the call, but also with the gathering of specific data such as medical social and psychological evaluation. These items allow the regulating doctor to assess comorbidity, on-going treatment, psycho-cognitive status, previous hospitalisations, social situation, and patient expectations and needs.

However, data collected in order to assess the situation on the phone and take the orientation decision are mainly limited to the severity of clinical symptoms. Medical, psychological and social aspects are rarely gathered, for several reasons :

Read more
  • Phone call shortness : emergency calls should be treated quickly
  • Regulating doctors are not trained to take in account the specificities or geriatric patients in their decision making. Besides, they are not informed about alternatives to the hospital emergency department, such as "geriatric channel" system.

An observational study was performed in 2012 on 692 calls about elderly patients referred to the SAMU centre 15 during 7 days : 63% of these patients were transferred to an emergency department. Regardless of severe cases "hospital regulation", 55% of the least serious cases ("liberal regulation") were transferred to an emergency department.

Regulation is inadequate to elderly patients for whom 1) the situation assessment and the appropriate decision making require specific items that are not known by regulating doctors, 2) the medical care and the clinical pathway could be improved by the knowledge of on-field "geriatric channel", 3) the emergency department care is particularly long, 4) and could be pernicious to younger patients.

1920 patients will be recruited between January 2016 and August 2017, including a 6 months wash-out in order to train regulating doctors. This training will include geriatric patient's specificities, and geriatric channels. A 12% difference between the 2 groups (before and after the training) is expected, considering a 80% statistical power. The design is a time series experiment.

Keywords
geriatric, emergency, clinical pathway, regulation, SAMU, training
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02712450
Study groupRoleWhat they receive
Control group* Patients included from January 2016 to August 2016 * Before regulating doctors training course
Experimental group* Patients included from January 2017 to August 2017 * After regulating doctors training course

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients sent to an emergency department

    The training course efficiency (which contains specific regulation tools and emergency regulation doctors formation) will be assessed by evaluating the proportion of 75 years old patients and older sent to an emergency department after a liberal regulation.

    Measured: 24 hours after patient's call

Secondary outcomes (7)
  1. Duration of the hospital stay in emergency department

    The training course efficiency on hospital stay duration will be assessed by evaluating the duration of the hospital stay in emergency department, after regulating doctor decision.

    Measured: 7 days after patient's call

  2. Occurence of non-programmed hospitalization in emergency department

    The training course efficiency on non-programmed hospitalization in emergency department will be assessed by evaluating the occurence of these type of hospitalization one week after call regulation

    Measured: 7 days after patient's call

  3. Geriatric channel utilisation rate

    Training course efficiency on the geriatric channel utilization by regulating doctors will be assessed using multiple parameters : geriatric hotline use, intra-hospital geriatric mobile team mobilisation, extra-hospital geriatric mobile team mobilisation, direct hospitalization in geriatric department

    Measured: 24 hours after patient's call

  4. Training course feasibility

    Training course feasibility will be assessed using multiple parameters : regulation call duration, regulating doctor orientation respect, contact between regulating doctor and physician (GP, geriatric doctor, emergency doctor, geriatric channel)

    Measured: 24 hours after patient's call

  5. Medical cost for patient

    Measured: 7 days after patient's call

  6. Non medical cost for patient

    Measured: 7 days after patient's call

  7. Training course cost

    Measured: 7 days after patient's call

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2016 (estimated)
  2. Study startJan 2016
  3. Primary completionAug 2017
  4. Study completionAug 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
2,279 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02712450
Sponsor's protocol ID
69HCL14_0449
Acronym
REGESA
Status last verified
Feb 2018
First submitted
16 Feb 2016
Last updated
26 Feb 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Foucaud A, Gilbert T, Vincent A, Jomard N, Comte B, Porthault S, Comte G, Theurey O, Gueugniaud PY, Bourelly L, Rabilloud M, Boutitie F, Douplat M, Tassa O, Haesebaert J, Termoz A, Schott AM. Evaluation of a training program for emergency medical service physician dispatchers to reduce emergency departments visits. J Am Geriatr Soc. 2023 Feb;71(2):484-495. doi: 10.1111/jgs.18101. Epub 2022 Nov 1.

    PubMed 36317929

Questions about this trial

What is this clinical trial studying?

An observational study of Emergency Geriatric Care, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients sent to an emergency department (time frame: 24 hours after patient's call). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02712450, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in